SCHEMBL7448293

SCHEMBL7448293

O=S(=O)(Nc1ccc2nc(Cc3ccc(Oc4ccccc4)cc3)[nH]c2c1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 13/20 1.00
GRIN2B Q13224 13/20 1.00
F2 P00734 1/20 0.71
ALDH1A1 P00352 3/20 0.54
LMNA P02545 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
PGR P06401 1/20 0.53
NPC1 O15118 2/20 0.52
MAPT P10636 2/20 0.52
RAB9A P51151 2/20 0.52
HPGD P15428 1/20 0.52
MEN1 O00255 2/20 0.51
TP53 P04637 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
HSD17B10 Q99714 1/20 0.51
NPSR1 Q6W5P4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7452878 0.88 GRIN1 (1.00) GRIN1GRIN2BF2PGR
SCHEMBL7512485 0.87 GRIN1 (0.77) GRIN1GRIN2BF2SMN1; SMN2PGR
SCHEMBL7509280 0.86 GRIN1 (0.76) GRIN1GRIN2BF2HPGD
SCHEMBL7518591 0.86 GRIN1 (0.75) GRIN1GRIN2BF2PGR
SCHEMBL7513211 0.86 GRIN1 (0.75) GRIN1GRIN2BF2ALDH1A1LMNA
SCHEMBL7502977 0.86 GRIN1 (0.75) GRIN1GRIN2BF2PGR
SCHEMBL7516788 0.85 GRIN1 (0.74) GRIN1GRIN2BF2PGR
SCHEMBL7456255 0.85 GRIN1 (1.00) GRIN1GRIN2BF2
SCHEMBL7510373 0.84 GRIN1 (0.73) GRIN1GRIN2BF2PGR
SCHEMBL7511558 0.84 GRIN1 (0.72) GRIN1GRIN2BF2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242076-A4 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2002-11-27 EP claimed
EP-1242076-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP claimed
US-6316474-B1 TREATMENT OF PAIN, SCHIZOPHRENIA, PARKINSON'S DISEASE, STROKE AND DEPRESSION MERCK & CO., INC. 2001-11-13 US claimed
WO-2001032174-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO claimed
EP-1242076-A4 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1242076-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP disclosed
WO-2001032174-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed